Most patients opt for compounded formulations unless they specifically want FDA-approved brand-name medication or their insurance covers a portion of the cost
However, deviating from recommended doses can lead to adverse effects and accidental overdoses
Exenatide as a weight-loss therapy in extreme pediatric obesity: a randomized, controlled pilot study

Tesofensine May Be Better For: Patients who strongly prefer oral medication over injections Individuals whose eating patterns are driven primarily by cravings, emotional eating, or reward-seeking behavior (dopamine-mediated eating) Patients who have not responded adequately to GLP-1 medications Those who tolerate stimulant-type medications well Individuals without significant cardiovascular risk factors Semaglutide May Be Better For: Patients with type 2 diabetes or prediabetes (dual benefit of weight loss and glycemic control) Individuals with cardiovascular disease or elevated cardiovascular risk (proven cardioprotective benefit) Patients who prefer weekly dosing over daily medication Those who experience primarily volume-driven overeating rather than craving-driven eating Individuals with a history of anxiety or insomnia (since semaglutide does not have stimulant properties) Combination Therapy Some physicians prescribe tesofensine and semaglutide together, leveraging their complementary mechanisms tesofensine addressing central nervous system-mediated cravings while semaglutide handles peripheral satiety and metabolic improvements

[1] [2] Approved in November 2023, Zepbound represents a novel therapeutic approach for significant weight reduction
A small air bubble may remain at the needle tip, but it will not be injected